Age and legal capacity
Applicants must be adults and fall within current clinical and program criteria. Professional guidance generally prefers oocyte donors in the young-adult age range.
Eligibility and answers
Start with honest questions—not a perfect profile.
Basic criteria can help you decide whether to apply. Only an individualized review can determine whether you may proceed.
Eligibility preview
What RCA may need to review.
Program criteria can change and may include additional requirements. If you are unsure, a short application lets the team review rather than asking you to self-diagnose.
General and reproductive health
History, examination, ovarian assessment, medications, and ability to complete a monitored cycle are considered.
Personal and family history
Accurate multigenerational information supports genetic and medical review; missing information may require follow-up.
Nicotine, substance, and medication review
Current use and exposure can affect eligibility and safety. Disclose honestly so the clinical team can advise you appropriately.
Schedule and reliability
Appointments and medication timing matter. Travel, work, school, and caregiving obligations should be discussed early.
Voluntary informed choice
You should understand the process, risks, privacy implications, and future considerations without pressure to proceed.
RCA does not publish rigid medical cutoffs here because eligibility is clinical, criteria can change, and online screening cannot replace evaluation.
Frequently asked
Questions prospective donors ask.
Does applying commit me to donate?
No. The initial application begins a review and conversation. Later stages have their own consent and planning requirements.
Why is screening extensive?
Screening supports donor safety, recipient decision-making, regulatory donor eligibility, and responsible clinical care. It also has limits that the team should explain.
Will I give myself injections?
Donor cycles commonly involve self-administered medications after training. Your prescription, dose, timing, and instructions must come from the treating team.
What are the risks?
Medication side effects, procedure and anesthesia risks, ovarian hyperstimulation, emotional effects, and rare complications should be reviewed during informed consent. Individual risk requires clinician discussion.
How is compensation discussed?
RCA confirms the current program terms and expense arrangements directly. Compensation recognizes time, inconvenience, and commitment; it does not buy eggs or guarantee an outcome.
What happens to my information?
Basic public-site inquiries are separate from detailed health and family-history information, which belongs in the secure application and authorized clinical systems.
Not sure?